Bulgaria´s Positive Drug List inclusion criteria, in effect since April 1, 2019. Interactive and Static Maps.
PDL Inclusion Rules
Rules for the inclusion of products in the Positive Drug List (the Formulary). And specifically:
- RED: A product will be included in the PDL only if it is reimbursed by at least one public health care fund in one of the following countries: BE, EL, DK, EE, ES, IT, LT, LV, PL, PT, RO, SK SL, HU, FI, FR or CZ.
- GREEN: A drug will be listed in the Positive Drug List, only if a favorable HTA opinion has been already granted in one of the following countries: UK, DE or SE, and FR.
- New generic drugs MNF price must not exceed 70% of the reference product price / Biosimilars MNF price should not exceed 80% of the reference product price.
Bulgaria´s Positive Drug List Inclusion Criteria, Static Map 2019. Click on image to enlarge. Note, that if unchanged, these images can be used in your digital presentations. These images are not suitable for printing and hardcopy distribution. Pending copyrights by the Author.
Status: Up to date, last updated April 2019.